|
JAMA |
Collaborative Modeling to Compare Different Breast Cancer Screening Strategies - A Decision Analysis for the US Preventive Services Task Force |
1 |
Yes |
4/30/2027 |
|
JAMA |
Communication About Harm Reduction With Patients Who Have Opioid Use Disorder |
1 |
Yes |
11/18/2027 |
|
AMA Journal of Ethics |
Community Mental Health Centers' Roles in Depolicing Medicine |
1 |
Yes |
2/18/2028 |
|
JAMA |
Community-Acquired Pneumonia - A Review |
1 |
Yes |
9/16/2027 |
|
Oregon Health & Science University School of Medicine |
COMPADRE Educator Development Community Learning |
40 |
No |
12/31/2025 |
|
JAMA |
Comparative Safety of In Utero Exposure to Buprenorphine Combined With Naloxone vs Buprenorphine Alone |
1 |
Yes |
8/12/2027 |
|
JAMA Network Open |
Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada |
1 |
Yes |
8/8/2025 |
|
JAMA Neurology |
Computer Vision in Clinical Neurology - A Review |
1 |
Yes |
2/17/2028 |
|
JAMA |
Concordance of SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents |
1 |
Yes |
8/30/2025 |
|
American Medical Association |
Confronting Ageism in Medicine |
0.5 |
Yes |
11/26/2027 |
|
JAMA Otolaryngology – Head & Neck Surgery |
Congenital Cutaneous Sinus at the Sternoclavicular Joint |
1 |
Yes |
7/25/2027 |
|
JAMA Ophthalmology |
Conjunctival Nodule in a Female With Ulcerative Colitis |
1 |
Yes |
3/6/2028 |
|
JAMA Oncology |
Contemporary Management of Acute Myeloid Leukemia - A Review |
1 |
Yes |
8/8/2027 |
|
American Medical Association |
Contracting in Private Practice |
0.25 |
Yes |
2/6/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Controlled Substances Series: Arkansas License Renewals |
1.25 |
Yes |
2/9/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Controlled Substances Series: Best Practices for Prescribing |
1.25 |
Yes |
2/9/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Controlled Substances Series: Drug Diversion Prevention |
0.75 |
Yes |
2/9/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Controlled Substances Series: Fundamentals of Addiction and Addiction Treatment |
1.25 |
Yes |
2/9/2027 |
|
JAMA Ophthalmology |
Corneal Degeneration Secondary to Vernal Keratoconjunctivitis |
1 |
Yes |
2/20/2028 |
|
JAMA Ophthalmology |
Corneal Recovery After Neurotization for Neurotrophic Keratopathy |
1 |
Yes |
2/20/2028 |
